These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 27975102)

  • 21. Atherosclerosis and autoimmunity: a growing relationship.
    Sanjadi M; Rezvanie Sichanie Z; Totonchi H; Karami J; Rezaei R; Aslani S
    Int J Rheum Dis; 2018 May; 21(5):908-921. PubMed ID: 29671956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting inflammation: impact on atherothrombosis.
    Marini MG; Sonnino C; Previtero M; Biasucci LM
    J Cardiovasc Transl Res; 2014 Feb; 7(1):9-18. PubMed ID: 24327329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interplay between hypercholesterolaemia and inflammation in atherosclerosis: Translating experimental targets into clinical practice.
    Tuñón J; Bäck M; Badimón L; Bochaton-Piallat ML; Cariou B; Daemen MJ; Egido J; Evans PC; Francis SE; Ketelhuth DF; Lutgens E; Matter CM; Monaco C; Steffens S; Stroes E; Vindis C; Weber C; Hoefer IE;
    Eur J Prev Cardiol; 2018 Jun; 25(9):948-955. PubMed ID: 29759006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease.
    Maranhão RC; Leite AC
    Curr Pharm Des; 2015; 21(9):1196-204. PubMed ID: 25312729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation in atherosclerosis: transition from theory to practice.
    Libby P; Okamoto Y; Rocha VZ; Folco E
    Circ J; 2010 Feb; 74(2):213-20. PubMed ID: 20065609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory Cytokines and Atherosclerotic Plaque Progression. Therapeutic Implications.
    Sterpetti AV
    Curr Atheroscler Rep; 2020 Oct; 22(12):75. PubMed ID: 33025148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mast cells as effectors in atherosclerosis.
    Bot I; Shi GP; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):265-71. PubMed ID: 25104798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional diversity of macrophages in vascular biology and disease.
    Park I; Kassiteridi C; Monaco C
    Vascul Pharmacol; 2017 Dec; 99():13-22. PubMed ID: 29074468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelets in atherosclerosis.
    Lievens D; von Hundelshausen P
    Thromb Haemost; 2011 Nov; 106(5):827-38. PubMed ID: 22012554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dead cell and debris clearance in the atherosclerotic plaque: Mechanisms and therapeutic opportunities to promote inflammation resolution.
    Dhawan UK; Singhal A; Subramanian M
    Pharmacol Res; 2021 Aug; 170():105699. PubMed ID: 34087352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From Lipids to Inflammation: New Approaches to Reducing Atherosclerotic Risk.
    Shapiro MD; Fazio S
    Circ Res; 2016 Feb; 118(4):732-49. PubMed ID: 26892970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammation and atherosclerosis--revisited.
    Pant S; Deshmukh A; Gurumurthy GS; Pothineni NV; Watts TE; Romeo F; Mehta JL
    J Cardiovasc Pharmacol Ther; 2014 Mar; 19(2):170-8. PubMed ID: 24177335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy.
    Fredman G; Tabas I
    Am J Pathol; 2017 Jun; 187(6):1211-1221. PubMed ID: 28527709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atherosclerosis.
    Lu H; Daugherty A
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):485-91. PubMed ID: 25717174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obesity, inflammation, and atherosclerosis.
    Rocha VZ; Libby P
    Nat Rev Cardiol; 2009 Jun; 6(6):399-409. PubMed ID: 19399028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunity and Inflammation in Atherosclerosis.
    Wolf D; Ley K
    Circ Res; 2019 Jan; 124(2):315-327. PubMed ID: 30653442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stabilizing the vulnerable plaque: the search for the magic bullet.
    Pasterkamp G; Daemen M
    Curr Pharm Des; 2007; 13(10):979-82. PubMed ID: 17430161
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial.
    Emami H; Vucic E; Subramanian S; Abdelbaky A; Fayad ZA; Du S; Roth E; Ballantyne CM; Mohler ER; Farkouh ME; Kim J; Farmer M; Li L; Ehlgen A; Langenickel TH; Velasquez L; Hayes W; Tawakol A
    Atherosclerosis; 2015 Jun; 240(2):490-6. PubMed ID: 25913664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unmet needs in the management of atherosclerotic cardiovascular disease: Is there a role for emerging anti-inflammatory interventions?
    Lorenzatti AJ; Retzlaff BM
    Int J Cardiol; 2016 Oct; 221():581-6. PubMed ID: 27420583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential applications of mushrooms against some facets of atherosclerosis: A review.
    Amirullah NA; Zainal Abidin N; Abdullah N
    Food Res Int; 2018 Mar; 105():517-536. PubMed ID: 29433243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.